A detailed history of Lam Group, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Lam Group, Inc. holds 130,800 shares of AMPH stock, worth $5.83 Million. This represents 5.03% of its overall portfolio holdings.

Number of Shares
130,800
Previous 130,800 -0.0%
Holding current value
$5.83 Million
Previous $5.23 Billion 99.88%
% of portfolio
5.03%
Previous 4.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$44.49 - $62.93 $124,572 - $176,204
2,800 Added 2.19%
130,800 $8.09 Billion
Q2 2023

Jul 14, 2023

SELL
$35.77 - $58.38 $80,482 - $131,355
-2,250 Reduced 1.73%
128,000 $7.36 Billion
Q4 2022

Jan 12, 2023

BUY
$27.93 - $31.27 $3.64 Million - $4.07 Million
130,250 New
130,250 $3.65 Billion

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.18B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Lam Group, Inc. Portfolio

Follow Lam Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lam Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lam Group, Inc. with notifications on news.